Although additional studies are needed for confirmation, our study underscores the potential role of adipose-derived EV-miRNAs in the regulation of fat redistribution and insulin function in people with type 2 diabetes undergoing pioglitazone treatment. The gene discussed is INS; the disease is type 2 diabetes mellitus.